MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable
-$13,494K
Net loss
$5,155K
Inventory
-$1,126K
Net cash (used
in)/provided by operating...
$8,890K
Canceled cashflow
$11,277K
Increase in cash and cash
equivalents
$8,078K
Canceled cashflow
$812K
Equity-based compensation
-$3,521K
Accrued liabilities
-$2,851K
Other non-current
assets
$1,460K
Prepaid expenses
$1,404K
Accounts payable
-$979K
Other current assets
$891K
Allowance for credit
losses
-$120K
Amortization of contract
asset
-$51K
Net cash provided
by/(used in) by financing...
-$812K
Issuance of shares,
options exercise
-$662K
Cash paid for taxes on
restricted share release
$150K
Back
Back
Cash Flow
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)
source: myfinsight.com